One-Month Outcomes of Cases Receiving Ticagrelor after Percutaneous Coronary Intervention; a Case Series

INTRODUCTION: Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist that can block ADP-induced platelet aggregation. This study aimed to describe one-month follow-up findings of cases undergoing ticagrelor therapy after percutaneous coronary intervention (PCI). METHODS: This case...

Descripción completa

Detalles Bibliográficos
Autores principales: Namazi, Mohammad Hasan, Saemifard, Farzam, Pishgahi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130436/
https://www.ncbi.nlm.nih.gov/pubmed/32259131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130436/
https://www.ncbi.nlm.nih.gov/pubmed/32259131

Ejemplares similares